Larsson A - Search Results

1

The influence of the molecular weight of the water-soluble polymer on phase-separated films for controlled release.

Andersson H, Häbel H, Olsson A, Sandhagen S, von Corswant C, Hjärtstam J, Persson M, Stading M, Larsson A. Andersson H, et al. Among authors: larsson a. Int J Pharm. 2016 Sep 10;511(1):223-235. doi: 10.1016/j.ijpharm.2016.06.058. Epub 2016 Jun 24. Int J Pharm. 2016. PMID: 27349793

2

Initial studies of water granulation of eight grades of hypromellose (HPMC).

Herder J, Adolfsson A, Larsson A. Herder J, et al. Among authors: larsson a. Int J Pharm. 2006 Apr 26;313(1-2):57-65. doi: 10.1016/j.ijpharm.2006.01.024. Epub 2006 Feb 28. Int J Pharm. 2006. PMID: 16510256

3

New release cell for NMR microimaging of tablets. Swelling and erosion of poly(ethylene oxide).

Abrahmsén-Alami S, Körner A, Nilsson I, Larsson A. Abrahmsén-Alami S, et al. Among authors: larsson a. Int J Pharm. 2007 Sep 5;342(1-2):105-14. doi: 10.1016/j.ijpharm.2007.05.005. Epub 2007 May 13. Int J Pharm. 2007. PMID: 17580107

4

Investigation of critical polymer properties for polymer release and swelling of HPMC matrix tablets.

Viridén A, Wittgren B, Larsson A. Viridén A, et al. Among authors: larsson a. Eur J Pharm Sci. 2009 Feb 15;36(2-3):297-309. doi: 10.1016/j.ejps.2008.10.021. Epub 2008 Nov 6. Eur J Pharm Sci. 2009. PMID: 19038336

5

The effect of substitution pattern of HPMC on polymer release from matrix tablets.

Viridén A, Larsson A, Wittgren B. Viridén A, et al. Among authors: larsson a. Int J Pharm. 2010 Apr 15;389(1-2):147-56. doi: 10.1016/j.ijpharm.2010.01.029. Epub 2010 Jan 25. Int J Pharm. 2010. PMID: 20100556

6

Effect of ethanol on the water permeability of controlled release films composed of ethyl cellulose and hydroxypropyl cellulose.

Larsson M, Hjärtstam J, Berndtsson J, Stading M, Larsson A. Larsson M, et al. Among authors: larsson a. Eur J Pharm Biopharm. 2010 Nov;76(3):428-32. doi: 10.1016/j.ejpb.2010.09.007. Epub 2010 Sep 18. Eur J Pharm Biopharm. 2010. PMID: 20854907

7

Model drug release from matrix tablets composed of HPMC with different substituent heterogeneity.

Viridén A, Larsson A, Schagerlöf H, Wittgren B. Viridén A, et al. Among authors: larsson a. Int J Pharm. 2010 Nov 30;401(1-2):60-7. doi: 10.1016/j.ijpharm.2010.09.017. Epub 2010 Sep 29. Int J Pharm. 2010. PMID: 20883761

8

The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility.

Viridén A, Wittgren B, Larsson A. Viridén A, et al. Among authors: larsson a. Eur J Pharm Biopharm. 2011 Jan;77(1):99-110. doi: 10.1016/j.ejpb.2010.11.004. Epub 2010 Nov 23. Eur J Pharm Biopharm. 2011. PMID: 21081160

9

Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.

Viridén A, Abrahmsén-Alami S, Wittgren B, Larsson A. Viridén A, et al. Among authors: larsson a. Eur J Pharm Biopharm. 2011 Aug;78(3):470-9. doi: 10.1016/j.ejpb.2011.02.003. Epub 2011 Feb 18. Eur J Pharm Biopharm. 2011. PMID: 21316446

10

Effects of molecular weight on permeability and microstructure of mixed ethyl-hydroxypropyl-cellulose films.

Andersson H, Hjärtstam J, Stading M, von Corswant C, Larsson A. Andersson H, et al. Among authors: larsson a. Eur J Pharm Sci. 2013 Jan 23;48(1-2):240-8. doi: 10.1016/j.ejps.2012.11.003. Epub 2012 Nov 16. Eur J Pharm Sci. 2013. PMID: 23159668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,132 results

Search Page

Filters